Enliven Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELVN and other ETFs, options, and stocks.

About ELVN

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates.

CEO

Samuel S. Kintz

CEOSamuel S. Kintz

Employees

Employees46

Headquarters

Boulder, Colorado

HeadquartersBoulder, Colorado

Founded

2019

Founded2019

Employees

Employees46

ELVN Key Statistics

Market cap

1.06B

Market cap1.06B

Price-Earnings ratio

-10.39

Price-Earnings ratio-10.39

Dividend yield

—

Dividend yield—

Average volume

357.95K

Average volume357.95K

High today

$23.00

High today$23.00

Low today

$21.35

Low today$21.35

Open price

$21.81

Open price$21.81

Volume

482.54K

Volume482.54K

52 Week high

$26.00

52 Week high$26.00

52 Week low

$9.80

52 Week low$9.80

Enliven Therapeutics

Why Robinhood?

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. Show more

ELVN Key Statistics

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates.